Clinical Trial of Daily Low-Dose Oral Etoposide for Patients with Residual or Recurrent Cancer of the Ovary or Uterus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Trial of Daily Low-Dose Oral Etoposide for Patients with Residual or Recurrent Cancer of the Ovary or Uterus

Published:1995-12 Issue:6 Volume:21 Page:569-576
ISSN:1340-9654
Container-title:Journal of Obstetrics and Gynaecology
language:en
Short-container-title:

Author:

Yasumizu Takehiko,Kato Junzo

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1447-0756.1995.tb00914.x/fullpdf

Reference24 articles.

1. Multicenter phase II trial of etoposide in refractory small cell lung cancer;Issell;Cancer Treat Rep,1985

2. Phase II study of daily oral VP-16 in refractory germ cell tumor;Miller;Proc Am Soc Clin Oncol,1989

3. The epipodophyllotoxin derivatives VM-16 and VP-16-213, 1976-1979, a review;Nissen;Rec Results Cancer Res,1980

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remarkable response of recurrent endometrial adenocarcinoma to daily oral administration of half-dose etoposide;SAGE Open Medical Case Reports;2018-01

2. Etoposide sensitizes CT26 colorectal adenocarcinoma to radiation therapy in BALB/c mice;World Journal of Gastroenterology;2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP